Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 585

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 585
---
 follows:(In millions)December 31, 2024December 31, 2023Cash and cash equivalents$1,339 $467 Investments1,444 1,438 Accounts receivable, net1,927 1,122 Other assets, including Goodwill (1)2,294 2,963 Total assets of businesses held for sale7,004 5,990 Insurance and contractholder liabilities1,579 1,636 All other liabilities831 1,059 Total liabilities of businesses held for sale$2,410 $2,695 (1) Includes Goodwill of $94 million as of December 31, 2024 and $396 million as of December 31, 2023.Integration and Transaction-Related CostsIn 2024 and 2023, the Company incurred transaction-related costs associated with the HCSC transaction. In 2023 and 2022, the Company also incurred net costs mainly related to the sale of our international life, accident and supplemental benefits businesses. Additionally in 2022, the Company incurred costs related to the sale of the Group Disability and Life business as well as the acquisition of MDLIVE, Inc. ("MD Live"). These costs incurred consisted primarily of certain projects to separate or integrate the Company's systems, products and services; fees for legal, advisory and other professional services; and certain employment-related costs. These costs were $275 million pre-tax ($211 million after-tax), $45 million pre-tax ($35 million after-tax) and $135 million pre-tax ($103 million after-tax) for the years ended December 31, 2024, December 31, 2023 and December 31, 2022, respectively.

Note 6 – Earnings Per Share

Accounting Policy. The Company computes basic earnings per share using the weighted-average number of unrestricted common and deferred shares outstanding. Diluted earnings per share also includes the dilutive effect of outstanding employee stock options and restricted stock using the treasury stock method and the effect of strategic performance shares.

Basic and diluted earnings per share were computed as follows:

For the Years Ended December 31,202420232022(Shares in thousands, dollars in millions, except per share amounts)BasicEffect ofDilutionDilutedBasicEffect ofDilutionDilutedBasicEffect ofDilutionDilutedShareholders' net income$3,434 $3,434 $5,164 $5,